J9190 HCPCS Level II code: Injection, fluorouracil, 500 mg
CMS terminated J9190: its last date of service was Sep 30, 2026. It stays here for looking up older claims; newer services need a current code.
Official description
J9190Injection, fluorouracil, 500 mg
Short description: Fluorouracil injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9190 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1984
- Terminated after
- Sep 30, 2026
Where J9190 sits
- 1J codesDrugs administered other than orally
- 2Terminated J9190Injection, fluorouracil, 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J9190 still valid?
No. CMS terminated J9190; its last date of service was Sep 30, 2026. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J9190?
CMS lists J9190’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9190
All J codesJ9181Injection, etoposide, 10 mgJ9183Gemcitabine intravesical system, 225 mgJ9184Injection, gemcitabine hydrochloride (avyxa), 200 mgJ9185Injection, fludarabine phosphate, 50 mgJ9186Injection, etoposide (avyxa), 1 mgJ9187Injection, etoposide, 1 mgJ9191Injection, fluorouracil (avyxa), 10 mgJ9192Injection, fluorouracil, 10 mgJ9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mgJ9198Injection, gemcitabine hydrochloride, (infugem), 100 mgJ9199Injection, gemcitabine hydrochloride (infugem), 200 mgJ9200Injection, floxuridine, 500 mg